[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 5 - The Spring Supplement of Shefaye Khatam 2 - ::
Shefaye Khatam 2017, 5 - The Spring Supplement of Shefaye Khatam 2 -: 164-164 Back to browse issues page
P 133: Neuroinflammation in Alzheimer ’s Disease
Maryam MoghadamQaeini * , Zahra SheidaeMehne
Student Research Committee, Facuilty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad, Iran , Maryammghdm20@gmail.com
Abstract:   (2990 Views)

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common form of dementia. Almost 47 million people suffer from dementia worldwide. AD accounts for approximately 60%–80% of all dementia cases. Three major pathologies characterize the disease: senile plaques, neurofibrillary tangles and inflammation. We review the literature on events contributing to the inflammation. Those inflammatory processes play a significant role in the pathophysiology of AD. Histopathologically is characterized by the presence of two major hallmarks, the intracellular neurofibrillary tangles (NFTs) and extracellular neuritic plaques (NPs) surrounded by activated astrocytes and microglia. The main component in the NP is the amyloid-β peptide (Aβ). Neuroinflammation is characterized by the activation of astrocytes and microglia and the release of proinflammatory cytokines and chemokines. Neuroinflammation is one of the main factors neurodegenerations. Study of the factors and pathways able to the first step of the inflammatory response induced to identify potential therapeutic targets through which to stop the progress AD. Evidence confirms that neuroinflammation, by neuronal, glial, and immune components, is a contributing cause of Aβ aggregation, tau hyper phosphorylation, and neuronal damage and death, so production of cytokines and pro-inflammatory molecules has initially a neuroprotective role, but subsequently becomes the cause of further neurodegeneration. Therefore, future studies must intensively investigate the intricate ways of the neuroinflammatory process and define the best time to control it, so it will be possible to achieve more focused therapeutic strategies in the hope of not only alleviating but also modifying AD progression.

Keywords: Alzheimer’s disease, Neuroinflammation, Amyloid-β
Full-Text [PDF 211 kb]   (829 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

MoghadamQaeini M, SheidaeMehne Z. P 133: Neuroinflammation in Alzheimer ’s Disease. Shefaye Khatam 2017; 5 (S2) :164-164
URL: http://shefayekhatam.ir/article-1-1321-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 5 - The Spring Supplement of Shefaye Khatam 2 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.06 seconds with 45 queries by YEKTAWEB 4645